Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan

Limited real-world data are available regarding treatment practices and outcomes of multiple myeloma (MM) in Asia. We conducted a retrospective cohort study using the Taiwan National Healthcare Insurance Research database and Taiwan Death Registry and used a Markov model to describe disease progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanfang, Tang, Chao-Hsiun, Qiu, Hong, Siggins, Sarah, Hou, Hsin-An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806818/
https://www.ncbi.nlm.nih.gov/pubmed/33441901
http://dx.doi.org/10.1038/s41598-020-80607-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806818/
https://www.ncbi.nlm.nih.gov/pubmed/33441901
http://dx.doi.org/10.1038/s41598-020-80607-4

Ejemplares similares